Category: Prevention
Advancing Melanoma Research in Times of Uncertainty
By Cody R. Barnett, MRA Director of Communications | 9 June 2021 In Allies & Partnerships, Melanoma Stories, Policy, Prevention, Science, Treatment
Each year, the annual MRA Scientific Retreat brings hundreds of people from across the melanoma research ecosystem together to exchange ideas, report on scientific progress, celebrate achievements, and mourn the losses. In these ways, the 2021 Retreat was no different.
SPOTMYUV: Your Sunscreen’s New Best Friend
By Cody R. Barnett, MRA Director of Communications | 20 May 2021 In Allies & Partnerships, Prevention
SPOTMYUV, a small, water-resistant sticker applied to any skin exposed to direct sunlight such as your arm or shoulder, helps the wearer know when it is time to reapply their sunscreen by changing color. Throughout the day, a SPOT sticker works to absorb the sunscreen’s UV protecting ingredients at about the same rate as your skin. The SPOT is clear when you are protected by your sunscreen and quickly turns into a deep purple as the sunscreen loses its effectiveness. By monitoring the SPOT, you get a real-time way to monitor your sunscreen without chancing sunburn.
Melanoma Research Alliance Announces $8.1 million in Research Awards
By Cody R. Barnett, MRA Director of Communications | 27 April 2021 In News, Prevention, Science, Treatment
The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce $8.1 million in funding for 34 new research awards. The awards, issued on the cusp of Melanoma Awareness Month, provide critical funding to address urgent unmet needs in melanoma.
Summer Kramer: Aligning Passion with Purpose
By Michael Kaplan, MRA President & CEO | 19 April 2021 In Allies & Partnerships, Melanoma Stories, Prevention
Frustrated with her inability to find stylish UPF protective clothing after her own melanoma diagnosis, Summer Kramer founded her own company called SUMMERSKIN. Now, eight years later, she has aligned her passion with purpose through a new partnership with the Melanoma Research Alliance.
UV Exposure & Risk of Cutaneous Melanoma in Skin of Color
By Rachel Fischer, Ph.D., Senior Associate, Scientific Program and Grants Administration | 14 April 2021 In News, Prevention, Science
In JAMA Dermatology, a team led by Adewole S. Adamson, MD, from The University of Texas at Austin, investigates whether there is an association, specifically in People of Color, between UV exposure and melanoma. MRA breaks down what this research means and how it should impact your sun safety practices.
Estimating Melanoma Risk by Examining Skin’s Mutational Burden
By Cody R. Barnett, MRA Director of Communications | 10 February 2021 In Prevention, Science
We’ve known for decades that most melanomas – formed from the color-producing cells in our skin called melanocytes – are predominantly caused by UV-radiation-induced damage from the sun or indoor tanning devices. This damage is cumulative but is often invisible.
Five Melanoma Research Highlights to Look Forward to in 2021
By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 13 January 2021 In Allies & Partnerships, News, Prevention, Science, Treatment
At MRA, every day we are focused on how melanoma research can be reimagined to accelerate progress similar to what has been accomplished in record time with COVID-19 research, and look forward to a future not only void of COVID-19; but where suffering and death due to melanoma are no more.
Fueling a Revolution: Driving Research Forward
21 October 2020 In Allies & Partnerships, Melanoma Stories, News, Policy, Prevention, Science, Treatment
MRA is powering a revolution in melanoma research. A revolution that is not only benefiting patients with melanoma but also impacting the field of oncology at large.
A Personal Journey, A Virtual Platform
23 June 2020 In Melanoma Stories, Prevention, Science
Meet Shirin Bajaj, a third-year resident at NYU’s School of Medicine and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.
Maintaining Momentum in Melanoma Research
8 June 2020 In Allies & Partnerships, News, Policy, Prevention, Science, Treatment
The last decade has been one of substantial progress and hope for many melanoma patients, researchers, and clinicians. With 12 new therapeutic approaches now approved to treat melanoma, many advanced-stage patients are seeing their tumors shrink or disappear, and are experiencing renewed hope for a brighter future.